Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoarthritis | 2 | 2005 | 73 | 0.360 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2007 | 683 | 0.310 |
Why?
|
| Takayasu Arteritis | 1 | 2005 | 4 | 0.270 |
Why?
|
| Vasculitis | 1 | 2005 | 39 | 0.270 |
Why?
|
| Uveitis | 1 | 2005 | 29 | 0.260 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 37 | 0.260 |
Why?
|
| Tramadol | 1 | 2005 | 14 | 0.260 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2005 | 46 | 0.250 |
Why?
|
| Acetaminophen | 1 | 2005 | 54 | 0.250 |
Why?
|
| Antibodies, Monoclonal | 3 | 2007 | 1376 | 0.230 |
Why?
|
| Analgesics, Opioid | 1 | 2005 | 413 | 0.190 |
Why?
|
| Lung Diseases, Interstitial | 2 | 2016 | 235 | 0.180 |
Why?
|
| Granulomatosis with Polyangiitis | 1 | 1997 | 9 | 0.150 |
Why?
|
| Sarcoidosis | 2 | 2007 | 71 | 0.140 |
Why?
|
| Connective Tissue Diseases | 1 | 2016 | 67 | 0.130 |
Why?
|
| Dermatomyositis | 2 | 2016 | 17 | 0.120 |
Why?
|
| Tacrolimus | 1 | 2016 | 373 | 0.120 |
Why?
|
| Pregnancy Complications | 1 | 1997 | 336 | 0.120 |
Why?
|
| Joint Instability | 1 | 1994 | 81 | 0.110 |
Why?
|
| Knee Joint | 1 | 1994 | 168 | 0.110 |
Why?
|
| Immunosuppressive Agents | 2 | 2016 | 977 | 0.110 |
Why?
|
| Infliximab | 3 | 2007 | 151 | 0.100 |
Why?
|
| Spondylitis, Ankylosing | 1 | 1991 | 24 | 0.100 |
Why?
|
| Spondylarthropathies | 1 | 2010 | 1 | 0.090 |
Why?
|
| Cryoglobulinemia | 1 | 2010 | 6 | 0.090 |
Why?
|
| Thalidomide | 1 | 2010 | 54 | 0.090 |
Why?
|
| Polymyositis | 1 | 2009 | 6 | 0.090 |
Why?
|
| Antibodies, Antinuclear | 1 | 2009 | 83 | 0.090 |
Why?
|
| Amyloidosis | 1 | 1991 | 115 | 0.090 |
Why?
|
| Nephrogenic Fibrosing Dermopathy | 1 | 2008 | 9 | 0.090 |
Why?
|
| Still's Disease, Adult-Onset | 1 | 2007 | 2 | 0.080 |
Why?
|
| Calcinosis | 1 | 2008 | 224 | 0.080 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2007 | 16 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2007 | 243 | 0.070 |
Why?
|
| Multiple Myeloma | 1 | 2010 | 307 | 0.070 |
Why?
|
| Retinal Diseases | 1 | 2007 | 90 | 0.070 |
Why?
|
| Skin Diseases | 1 | 2007 | 166 | 0.070 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2005 | 40 | 0.070 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2005 | 33 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2005 | 100 | 0.060 |
Why?
|
| Dermatologic Agents | 1 | 2005 | 71 | 0.060 |
Why?
|
| Adult | 8 | 2016 | 25648 | 0.060 |
Why?
|
| Drug Combinations | 1 | 2005 | 224 | 0.060 |
Why?
|
| Radiography | 2 | 2016 | 813 | 0.060 |
Why?
|
| Respiratory Function Tests | 2 | 2016 | 136 | 0.060 |
Why?
|
| Middle Aged | 6 | 2016 | 25028 | 0.050 |
Why?
|
| Humans | 12 | 2016 | 86643 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 1169 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2016 | 339 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 2360 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2005 | 1196 | 0.040 |
Why?
|
| Female | 6 | 2016 | 44532 | 0.040 |
Why?
|
| Methylprednisolone | 1 | 1997 | 66 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1997 | 70 | 0.040 |
Why?
|
| Aged | 5 | 2016 | 18415 | 0.040 |
Why?
|
| Cyclophosphamide | 1 | 1997 | 299 | 0.040 |
Why?
|
| Total Lung Capacity | 1 | 2016 | 5 | 0.030 |
Why?
|
| Vital Capacity | 1 | 2016 | 64 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 1997 | 247 | 0.030 |
Why?
|
| Rotation | 1 | 1994 | 89 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2016 | 263 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2016 | 268 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 894 | 0.030 |
Why?
|
| Male | 6 | 2016 | 40965 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2016 | 8489 | 0.030 |
Why?
|
| Movement | 1 | 1994 | 299 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 1991 | 130 | 0.020 |
Why?
|
| Amyloid | 1 | 1991 | 85 | 0.020 |
Why?
|
| HLA-B27 Antigen | 1 | 2010 | 8 | 0.020 |
Why?
|
| Sacroiliac Joint | 1 | 2010 | 7 | 0.020 |
Why?
|
| Pregnancy | 1 | 1997 | 2894 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2005 | 6509 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 2010 | 148 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2016 | 7993 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2008 | 94 | 0.020 |
Why?
|
| Etanercept | 1 | 2007 | 32 | 0.020 |
Why?
|
| Mouth Diseases | 1 | 2007 | 15 | 0.020 |
Why?
|
| Fundus Oculi | 1 | 2007 | 33 | 0.020 |
Why?
|
| Skin Ulcer | 1 | 2007 | 25 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2008 | 207 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2007 | 88 | 0.020 |
Why?
|
| Biopsy | 1 | 1991 | 1163 | 0.020 |
Why?
|
| Skin | 1 | 2008 | 554 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2007 | 456 | 0.020 |
Why?
|
| Kidney | 1 | 1991 | 1241 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 2008 | 509 | 0.010 |
Why?
|
| Hypertension | 1 | 2008 | 1141 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 5976 | 0.010 |
Why?
|